FOXO TECHNOLOGIES INC. Business Combination, Consideration Transferred
FOXO TECHNOLOGIES INC. (FOXO) reported Business Combination, Consideration Transferred of $22.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Notes
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2024-11-19
- FOXO TECHNOLOGIES INC. business combination, consideration transferred for the quarter ending 2024-09-30 was $21.50M.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month |
|---|---|---|---|
| 2024-09-30 | $21.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $22.00M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $500.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |